HIGHLIGHTS
- who: Spondyloarthritis from the Division of Clinical Immunology, Department of Clinical, Anesthesiologic and Cardiovascular Sciences, Sapienza University of Rome, Rome, Italy have published the article: Janus Kinase Inhibitors: A New Tool for the Treatment of Axial, in the Journal: (JOURNAL)
- what: The aim of this review is to discuss the efficacy and safety of these molecules in axSpA therapy. Although this analysis showed a greater reduction in inflammatory segments of the spine evaluated, no improvement in bone erosion or new bone formation was observed. The aim of this study was to evaluate the safety of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.